Association of the polymorphisms of TRAF1 (rs10818488) and TNFAIP3 (rs2230926) with rheumatoid arthritis and systemic lupus erythematosus and their relationship to disease activity among Egyptian patients
- PMID: 27536202
- PMCID: PMC4967658
- DOI: 10.5114/ceji.2016.60991
Association of the polymorphisms of TRAF1 (rs10818488) and TNFAIP3 (rs2230926) with rheumatoid arthritis and systemic lupus erythematosus and their relationship to disease activity among Egyptian patients
Abstract
Aim of the study: Recent studies demonstrated the association of tumor necrosis factor α-induced protein 3 (TNFAIP3) (rs2230926) and tumor necrosis factor receptor associated factor 1 (TRAF1) (rs10818488) with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) in different populations. We aimed at determining whether they confer susceptibility to SLE and RA in Egyptian population and if there is any relation to disease activity and auto-antibodies profile.
Material and methods: A case-control study involving 105 individuals with RA, 90 with SLE and 75 healthy controls was performed using TaqMan genotyping assay for two SNPs that showed the best evidence of association in the previous Caucasian studies.
Results: We detected significant differences in G allele frequency of TNFAIP3 (rs2230926) with SLE (p = 0.017(*)) and RA (OR = 2.333; 95% CI: 1.103-4.935, p = 0.023(*)) and association with RA disease activity (< 0.001). The A allele of TRAF1 was significantly increased in RA compared to controls(p = 0.049) and with RA activity (p = 0.001), while TRAF1 polymorphism did not exhibit any significant difference in the frequencies of genotypes or alleles in SLE and control (p = 0.280).
Conclusions: TNFAIP3 is a susceptibility gene to SLE and RA in the Egyptian population and is correlated to disease activity and the presence of autoantibodies while TRAF1 polymorphisms increase the risk of RA but not to SLE in Egyptian populations.
Keywords: TNFAIP3 gene; TRAF1; rheumatoid arthritis; systemic lupus erythematosus.
Similar articles
-
Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese.Ann Rheum Dis. 2010 Feb;69(2):368-73. doi: 10.1136/ard.2008.104315. Epub 2009 Mar 30. Ann Rheum Dis. 2010. PMID: 19336421
-
TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients.J Immunol Res. 2019 Aug 27;2019:6728694. doi: 10.1155/2019/6728694. eCollection 2019. J Immunol Res. 2019. PMID: 31534975 Free PMC article.
-
Association study of TRAF1/C5 polymorphism (rs10818488) with susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.Gene. 2013 Mar 15;517(1):46-54. doi: 10.1016/j.gene.2012.12.092. Epub 2013 Jan 13. Gene. 2013. PMID: 23321589
-
TNFAIP3 gene polymorphisms associated with differential susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Korean population.Rheumatology (Oxford). 2014 Jun;53(6):1009-13. doi: 10.1093/rheumatology/ket473. Rheumatology (Oxford). 2014. PMID: 24489017
-
Comprehensive review of genetic association studies and meta-analysis on miRNA polymorphisms and rheumatoid arthritis and systemic lupus erythematosus susceptibility.Hum Immunol. 2016 Jan;77(1):1-6. doi: 10.1016/j.humimm.2014.09.002. Epub 2014 Sep 16. Hum Immunol. 2016. PMID: 25218914 Review.
Cited by
-
A De Novo Frameshift Mutation in TNFAIP3 Impairs A20 Deubiquitination Function to Cause Neuropsychiatric Systemic Lupus Erythematosus.J Clin Immunol. 2019 Nov;39(8):795-804. doi: 10.1007/s10875-019-00695-4. Epub 2019 Oct 17. J Clin Immunol. 2019. PMID: 31625129
-
Molecular biology of autoinflammatory diseases.Inflamm Regen. 2021 Oct 11;41(1):33. doi: 10.1186/s41232-021-00181-8. Inflamm Regen. 2021. PMID: 34635190 Free PMC article. Review.
-
A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.Front Immunol. 2018 Feb 21;9:104. doi: 10.3389/fimmu.2018.00104. eCollection 2018. Front Immunol. 2018. PMID: 29515565 Free PMC article. Review.
-
Updates in Lupus Genetics.Curr Rheumatol Rep. 2017 Oct 5;19(11):68. doi: 10.1007/s11926-017-0695-z. Curr Rheumatol Rep. 2017. PMID: 28983873 Review.
-
Alterations and abnormal expression of A20 in peripheral monocyte subtypes in patients with rheumatoid arthritis.Clin Rheumatol. 2021 Jan;40(1):341-348. doi: 10.1007/s10067-020-05137-w. Epub 2020 Jun 2. Clin Rheumatol. 2021. PMID: 32488768
References
-
- Majithia V, Geraci SA. Rheumatoid arthritis: diagnosis and management. Am J Med. 2007;120:936–939. - PubMed
-
- Krishnan S, Chowdhury B, Juang Y-T, Tsokos GC. Overview of the pathogenesis of systemic lupus erythematosus. In: Tsokos GC, Gordon C, Smolen JS, editors. Systemic lupus erythematosus: acompanion to Rheumatology. Philadelphia: Mosby Inc; 2007. pp. 55–63.
-
- Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345:340–350. - PubMed
-
- Suzuki A, Kochi Y, Okada Y, Yamamoto K. Insight from genome-wide association studies in rheumatoid arthritis and multiple sclerosis. FEBS Lett. 2011;585:3627–3632. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials